Don’t feel like they have told us much in the last while. Was worried the defence grant could end up being more of a distraction from getting to market then anything else. Even though it wasn’t even mentioned in the quarterly key points. The key points were mostly about Hydrix and only a few commercial discussions from PSY.
At the time I thought, maybe they’re playing psy down a bit here. Why would they want to do that? To let their mates get in at a lower price? Who knows.
So far nothing but maybe there’s a surprise awaiting. Or maybe they’re purposely letting it fizzle out into a Hydrix operation because they’re not getting a bite on the commercial end of things with psys technology. I felt a warning flag with that quarterly and should have sold with my gut feeling. Unfortunately I didn’t and still hold in hope.
I myself have no expertise in this field and am just speculating randomness to bait a bit of discussion.
PSY Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
